• ABOUT
  • ADVERTISE
  • PRIVACY POLICY
  • TERMS OF USE
  • CAREERS
  • CONTACT
Monday, January 18, 2021
Subscribe to Newsletter
No Result
View All Result
Whistleblower Network News
  • Home
  • News
    • Corporate
    • Dodd-Frank
    • False Claims-Qui Tam
    • Foreign Corruption
    • Government
    • Intelligence
    • IRS & Tax
    • Legislation
    • OSHA
    • Sarbanes-Oxley
    • SEC
  • Editorial
  • Opinion
  • Whistleblower of the Week
Whistleblower Network News
  • Home
  • News
    • Corporate
    • Dodd-Frank
    • False Claims-Qui Tam
    • Foreign Corruption
    • Government
    • Intelligence
    • IRS & Tax
    • Legislation
    • OSHA
    • Sarbanes-Oxley
    • SEC
  • Editorial
  • Opinion
  • Whistleblower of the Week
No Result
View All Result
Whistleblower Network News
No Result
View All Result
Home News False Claims-Qui Tam

Novartis To Pay Over $642 Million To Settle Allegations of False Claims Act Violations

Peter BriccettibyPeter Briccetti
July 13, 2020
in False Claims-Qui Tam, Foreign Corruption, News
Reading Time: 2min read
0
Whistleblowers Awarded Over $1 Million After Reporting on City Corruption in Georgia
Share on TwitterShare on FacebookShare on LinkedInEmail

On July 1, Novartis Pharmaceuticals Corporation agreed to pay $642 million to settle a False Claims Act case brought by a whistleblower. The federal government claims that Novartis knowingly committed two kinds of fraud: first, that they funneled money through three different foundations to pay for otherwise unaffordable Medicare copays illegally. The second claim alleges that Novartis set up a kickbacks program for doctors and medical professionals to promote their drugs. These claims fall under the purview of the Anti-Kickback Statute, which prohibits any remuneration from encouraging referrals of any item or service that may be covered by Medicare or Medicaid. Improper payment of patients’ copays is considered a kickback under the statute.

To artificially inflate the prices of their drugs Gilenya and Afinitor, Novartis used foundations to illegally pay for hundreds of patients’ copays when they knew that without their help, patients would be unable to afford the drugs. This practice allowed them to charge Medicare much more than they would normally be able to charge for the drug. One purpose of copays is to check how much pharmaceutical companies charge for their drugs by ensuring a percentage of the total cost must be affordable to the patient, even if they are on Medicare or Medicaid. By paying patients’ copays, Novartis was illegally inflating the prices of their drugs.

RelatedPosts

Drone Manufacturing Company To Pay $25 Million For Making False Claims, Using Recycled Drone Parts

Department of Labor Awards Delta Air Lines Whistleblower $500,000 in Compensatory Damages

SEC Sets New Record for Money Awarded to Whistleblowers in a Fiscal Year

Load More

Novartis also allegedly engaged in another type of fraud: they built a campaign of thousands of speaker programs across the country used to bribe physicians. Novartis paid for expensive meals, top-shelf alcohol, and other lavish rewards to encourage doctors to prescribe their drugs. The government alleges that Novartis’s top management was involved in this scheme and directed sales representatives to drop doctors from the program who did not participate in the fraudulent activity. Sales representatives often picked high-volume prescribers of their drugs as speakers. Many events that were supposed to have an educational basis took place in restaurants, and no discussions of Novartis drugs took place. Many other events never even took place. Novartis agreed to pay over $591 million to the state and federal governments to resolve claims that it violated the False Claims Act.

Protect Yourself: Purchase the New Whistleblower Handbook Protect Yourself: Purchase the New Whistleblower Handbook Protect Yourself: Purchase the New Whistleblower Handbook

Whistleblower Oswald Bilotta, a former Novartis sales representative, first brought this qui tam complaint against Novartis in 2014. Under the False Claims Act, whistleblowers, or relators, are entitled to 15 to 30% of the funds the government recovers based on evidence they bring. The final amount of Bilotta’s whistleblower award is still to be determined, but it will undoubtedly be a large sum. The False Claims Act relies on whistleblowers like Bilotta to do the right thing and report fraud when they see it.

Read the DOJ press release: Novartis Pays Over $642 Million to Settle Allegations of Improper Payments to Patients and Physicians

Previous Post

SEC Posts Notice of Covered Action Regarding Penny Stock Scalping Case

Next Post

Piedmont Healthcare to Pay $16 Million to Settle False Claims Act Violations

Peter Briccetti

Peter Briccetti

Peter Briccetti is a contributing editor with Whistleblower Network News. He writes about breaking whistleblower news, and False Claims Act whistleblowers, FCPA whistleblowers, and tax fraud whistleblowers. Peter is a graduate of Hamilton College with a degree in History and an interest in politics and anti-corruption law. At Hamilton, he wrote for the Hamilton College Spectator as an editor and contributor.

Next Post
DOJ to Police Nursing Home Industry Using False Claims Act

Piedmont Healthcare to Pay $16 Million to Settle False Claims Act Violations

Write a Letter to The Editor.

Most Popular

Deutsche Bank to Pay over $130 Million to Settle FCPA Charges

1 week ago

Kim Farrington

7 days ago

Smart Home Tech Company Settles FIRREA Whistleblower Case With DOJ For $3.2 Million

5 days ago

President-elect Biden Nominates William J. Burns as Head of CIA

6 days ago

Taiwan Substantially Increases Awards for Financial Whistleblowers

6 days ago

Whistleblower to Receive $480,000 in Settlement, Lawyer Explains the Case

5 days ago

Whistleblower Poll

Increased Whistleblower Protections
Legislation

Candidate’s Position on Increased Whistleblower Protections Influences 44% of Likely Voters

byAna Popovich
October 6, 2020
0

Protect Yourself: Buy the New Whistleblower Handbook Protect Yourself: Buy the New Whistleblower Handbook Protect Yourself: Buy the New Whistleblower Handbook

STAY INFORMED. Sign up for daily whistleblower email and social notifications from the Whistleblower Network News.

  • This field is for validation purposes and should be left unchanged.

Qui Tam

  • Dodd-Frank
  • IRS & Tax
  • SEC
  • Foreign Corruption
  • False Claims-Qui Tam

Retaliation

  • OSHA
  • Sarbanes-Oxley

Government

  • Government
  • Intelligence
  • Legislation
  • Veterans

Features

  • Whistleblower of the Week
  • Editorial
  • Features
  • Interviews
  • Opinion

Resources

  • FAQs
  • National Whistleblower Day
  • National Whistleblower Center
  • Whistleblower Handbook
Whistleblower Network News

Whistleblower Network News is an independent online newspaper providing our readers with up-to-date information on whistleblowing. Our goal is to be the best source of information on important qui tam, anti-corruption, compliance, and whistleblower law developments. 

Submit an Article
  • ABOUT
  • ADVERTISE
  • PRIVACY POLICY
  • TERMS OF USE
  • CAREERS
  • CONTACT

Copyright © 2020, Whistleblower Network News. All Rights Reserved.

This Newspaper/Web Site is made available by the lawyer or law firm publisher for educational purposes only as well as to give you general information and a general understanding of the law, not to provide specific legal advice. By using this website, you understand that there is no attorney-client relationship between you and the Newspaper/Web Site publisher. The Newspaper/Web Site should not be used as a substitute for competent legal advice from a licensed professional attorney in your state.

No Result
View All Result
  • Home
  • News
    • Corporate
    • Dodd-Frank
    • False Claims-Qui Tam
    • Foreign Corruption
    • Government
    • Intelligence
    • IRS & Tax
    • Legislation
    • OSHA
    • Sarbanes-Oxley
    • SEC
  • Editorial
  • Opinion
  • Whistleblower of the Week
  • Login

Copyright © 2020, Whistleblower Network News. All Rights Reserved.

Welcome Back!

Sign In with Facebook
Sign In with Google
OR

Login to your account below

Forgotten Password?

Create New Account!

Sign Up with Facebook
Sign Up with Google
OR

Fill the forms below to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In
Go to mobile version